BriaCell Therapeutics Corp. (OTCMKTS:BCTXF – Get Free Report)’s share price rose 2.7% during mid-day trading on Friday . The company traded as high as $0.59 and last traded at $0.58. Approximately 438,013 shares were traded during trading, an increase of 23,462% from the average daily volume of 1,859 shares. The stock had previously closed at $0.57.
BriaCell Therapeutics Trading Up 10.5 %
The firm’s 50 day moving average price is $0.74 and its 200-day moving average price is $0.80. The company has a market cap of $494,620.40, a P/E ratio of 0.00 and a beta of 1.09.
About BriaCell Therapeutics
BriaCell Therapeutics Corp. operates as a clinical-stage biotechnology company that specializes in immunotherapy for advanced breast cancer. It is advancing its targeted immunotherapy program by conducting a Phase I/IIA clinical trial with Bria-IMT in combination with an immune checkpoint inhibitor and a companion diagnostic test, BriaDx, to identify patients to benefit from Bria-IMT.
Recommended Stories
- Five stocks we like better than BriaCell Therapeutics
- Do ETFs Pay Dividends? What You Need to Know
- Cold Front, Hot Stocks: Diesel Prices Propel Energy Leaders
- Election Stocks: How Elections Affect the Stock Market
- Sustainable and Successful: 3 Climate ETFs Beating the Market
- What Are Earnings Reports?
- Quantum Opportunity: Skywater Technology’s Long-Term Potential
Receive News & Ratings for BriaCell Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BriaCell Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
-logo-1200x675.png?v=20241112075050&h=45&w=95&zc=2){kind=logo}
